APLN and type 2 diabetes mellitus: Having a myriad of underlying metabolic abnormalities, which have implicated in the development and progression of HFpEF related to T2DM, the combination of biomechanical stress biomarker (NT-proBNP) and regulatory peptide with inotropic ability (apelin) seems to be promising [42].